Literatur
- 1
Szucs T D, Klose G, Düsing B.
Kosteneffektivität von Atorvastatin zur Prävention der koronaren Herzkrankheit.
Eine Analyse der ASCOT-Studie.
Dtsch Med Wochenschr.
2004;
129
1420-1424
- 2
Sever P S, Dahlöf B. et al. for the ASCOT investigators .
Prevention of coronary and stroke events with atorvastatin in hypertensive patients
who have average or lower-than-average Cholesterol concentrations, in the Anglo-Scandinavian
Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA).
Lancet.
2003;
361
1149-1158
Dr. med. Volker Traut
Am Himmelreich 1
79312 Emmendingen
